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Abstract
Background: Our objective was to describe the clinical presentation of  new diabetes patients in a rural hospital, to enhance 
clinical detection in low resource settings.
Methods: A case series assessment of  103 new diabetes patients consecutively enrolled at Iganga Hospital in rural Eastern 
Uganda was conducted. All underwent a basic clinical assessment through the clinic’s routine procedures.Following diagnosis, 
variables pertinent to the study (symptoms, blood pressure, anthropometry, and blood glucose) were secondarily abstracted from 
their clinical records. 
Results: Fiftty two percent of  new diabetes patients were female. The mean age was 49 years (SD=14.4). Two clinical symptoms 
were present in almost all new patients: Frequent urination (100%) and frequent thirst (79%). Moderately occurring symptoms 
(i.e. 25-50% of  patients) included blurred vision, frequent eating and frequent sweating. The mean duration of  symptoms was 
1.4 years; 48% had high blood pressure while 46% were overweight.  Random blood sugar was normal for 25% of  patients. The 
majority (71%) were classified as having ‘moderate illness’ at diagnosis. Severe illness was significantly lower among patients aged 
40 or older compared to younger patients (OR 0.1; 95% CI 0.03-0.35). 
Conclusion: Out-patients aged 40-65 years should be prioritised for early diabetes diagnosis and associated risk factors in this 
setting.
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Introduction
The rising burden of  type 2 diabetes in sub-Saharan Af-
rica1,2 calls for simplified approaches to identification of  
undetected cases at primary care facilities3. This requires 
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a good understanding of  how new patients present clin-
ically in a context where more robust diagnostics are of-
ten inaccessible. According to the International Diabetes 
Federation, there were an estimated 10 million cases of  
diabetes in Africa and diabetes accounted for an estimat-
ed 6% of  deaths on the continent in 20104. The substan-
tial advances in diagnosis, treatment and care for type 2 
diabetes seen in high income countries are currently out 
of  reach for many countries in sub-Saharan Africa5.
Diagnosis of  type 2 diabetes is based on assessment of  
blood glucose levels using either the Oral Glucose Tol-
erance Test (OGTT), Fasting Plasma Glucose (FPG) or 
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Glycated Haemoglobin (HbA1C). Diagnostic cut-offs for 
these tests have been defined by the World Health Organ-
isation (WHO) and the American Diabetes Association 
(ADA)6,7. In 2009, experts from the ADA, the European 
Association for the Study of  Diabetes, and the Interna-
tional Diabetes Federation recommended that HbA1C 
should be the primary test for early detection of  type 
2 diabetes and pre-diabetes in asymptomatic persons6. 
However, due to resource constraints and late presen-
tation, many health facilities in sub-Saharan Africa rely 
on random blood sugar (RBS),combined with explicit 
clinical symptoms for diagnosis of  diabetes8. Reliance on 
Random Blood Sugar as a diagnostic test for diabetes in 
this setting implies that  identifying asymptomatic diabe-
tes is hardly practical8. 
Because of  the inadequate diagnostic capacity in primary 
care facilities, the rate of  undiagnosed diabetes in sub-Sa-
haran Africa is high9. In Uganda for example, 49% of  
people with diabetes are unaware of  their status10. Evi-
dence shows that the majority of  people with diabetes 
in low income countries present late, by which time they 
have irreversible complications3,11. However, our current 
knowledge of  the clinical features of  new diabetes patients 
presenting to primary care facilities is insufficient.  One 
of  the few studies that described the clinical presentation 
of  newly diagnosed diabetes patients in Uganda showed 
that most patients presented with the classical symptoms 
of  diabetes and severe hyperglycaemia12. However, that 
study was conducted at the National Referral Hospital 
and similar information is not available for rural patients.
Rural clinics in sub-Saharan Africa rely substantially on 
overt clinical symptoms to identify people with diabetes11. 
In areas where more valid diagnostics are inaccessible, a 
clear understanding of  the clinical profile of  new patients 
can enhance the ability of  first level health workers to 
identify suspicious cases, thereby reducing missed oppor-
tunities for detection.  
Uganda’s response to Non Communicable Disease 
(NCD) is only evolving13 and the majority of  diabetes pa-
tients are managed at hospital level. Last revised  in 2010, 
the Uganda Clinical Guidelines do not provide detailed 
guidance on early detection of  type 2 diabetes14.  Detailed 
guidelines for management of  NCDs which were first de-
veloped in 199815, have only been updated  recently and 
have not been distributed to the districts. 
The objective of  this study was to describe the clinical 
presentation of  newly diagnosed diabetes patients in a 
rural district hospital in Eastern Uganda so as to foster 
a better understanding of  clinical features that can aid 
suspicion of  unrecognized disease in settings where di-
agnostic facilities are lacking. This will facilitate the im-
provement of  guidelines for passive case finding for un-
diagnosed diabetes in rural primary care facilities. 
Methods
Study site and context
The study was conducted at Iganga District Hospital, 
located in Eastern Uganda, about 120 kilometers from 
Kampala, the capital city of  Uganda. The district had 
an estimated population of  466,200 in 201316, with pub-
lic health centres, 83 (82%) of  which are government 
owned. Iganga Hospital is the only public hospital in the 
district, the rest being primary care facilities. The 100 bed 
hospital hosts the only diabetes clinic in the district, re-
ceiving patients from atleast five districts in the region. 
The diabetes clinic runs once a week on Tuesdays, and 
handles both type 1 and 2 diabetes. The clinic is run by a 
Clinical Officer (who undertakes the medical procedures 
including clinical assessments, requests for investigations, 
diagnosis and prescribing the requisite medications) and 
two nurses (who undertake basic physical assessments 
like anthropometry,administer the prescribed treatments, 
and provide health education). ‘Clinical Officers’ are a 
cadre of  medical practitioners who in many countries in 
sub-Saharan Africa are equivalent to ‘assistant doctors’. 
They are trained to handle minor out-patient medical and 
surgical tasks.  However, because of  severe shortages of  
qualified staff  in Uganda’s primary health care facilities, 
Clinical Officers often handle some specialised medical 
tasks that should be handled by Medical Officers, includ-
ing diabetes care. The diabetes clinic at Iganga Hospital 
receives patients referred from the hospital’s out-patients’ 
department based on their symptoms at presentation. At 
the diabetes clinic, they are assessed and investigated by 
the attending clinical officer who then affirms the diag-
nosis. Those diagnosed with diabetes are recorded in a 
diabetes register and initiated on treatment by the Clinical 
Officer. All diabetes patients are required to keep a record 
book in which findings from their regular clinical evalu-
ations are recorded by the attending clinical and nursing 
staff. 
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The study population comprised all newly diagnosed di-
abetes patients (both type 1 and type 2) seen at Iganga 
Hospital’s diabetes clinic from 1st January 2013 to 30th 
June 2014, a period of  approximately 18 months. Ap-
proximately 90% of  the population in Iganga resides in 
the rural areas with subsistence agriculture as the main 
economic activity. The main language in the region is ‘Lu-
soga’ a Bantu dialect.  
Study design
A case series study design involving a prospective second-
ary review of  clinical records of  all incident diabetes pa-
tients (both type-1 and type-2) seen over the study period 
was conducted. The rationale for using incident cases was 
to enable description of  patients’ clinical characteristics at 
the time when they had just been diagnosed with diabe-
tes. The minimum sample size required for determining 
the clinical characteristics of  diabetes patients, at a con-
fidence of  level of  95%, a precision of  6%, an estimated 
prevalence of  the most common clinical characteristic 
of  90% and 5% possible unusable records was 102 pa-
tients. Obtaining this number of  incident cases required 
18 months of  data collection. The estimated sample size 
was only sufficient for describing clinical characteristics 
of  diabetes patients in general but would not enable strat-
ification by type of  diabetes (type-1 or 2).
Data collection procedures
Only new patients with a final diagnosis of  type-1 or 
type-2 diabetes, affirmed by an entry into the hospital’s 
diabetes register during the study period, were included 
in this study. Data collection involved a secondary review 
of  clinical records. The clinicians’ assessments and initial 
management of  newly confirmed diabetes patients were 
reviewed to extract data on the variables pertinent to the 
study. The clinical records were reviewed at the specific 
visit when the diagnosis of  diabetes was made, after the 
patient had received care. Therefore, the data collection 
team did not undertake any direct clinical assessment on 
participants but rather reviewed data already recorded 
by the attending clinicians. Patients clinical records were 
taken from two main sources: the patients’ information 
entered into the diabetes clinic register as well as the pa-
tients’ individual record books. At Iganga hospital, par-
ticulars of  all diabetes patients are entered into a register 
that captures patient demographic characteristics. Addi-
tional information regarding the blood glucose level at 
diagnosis, clinical presentation, laboratory test results, the 
initial diagnosis and the treatment given are recorded in 
a note book kept by the patient and presented at every 
clinic day. Data collection was limited to variables that are 
routinely assessed and recorded by the clinicians. A data 
abstraction tool was used to extract the patient informa-
tion from both the patient register and the patient note 
books. The data abstraction tool was administered by two 
nurse research assistants.
For each patient, data on the following variables were ab-
stracted from their clinical records: Demographic char-
acteristics (age, sex, occupation, education level), family 
history of  diabetes, main symptoms at presentation and 
when they started, anthropometry (height, weight), blood 
pressure (BP), laboratory investigations done and their 
outcomes (including blood glucose tests, chest x-rays, eye 
examination), and the initial management decision after 
diagnosis (initiation on either oral hypoglycaemic drugs 
or insulin as an out-patient, initiation on lifestyle mea-
sures alone or admission to treat an emergency compli-
cation).
Nurses and clinicians in the diabetes clinic routinely as-
sess these characteristics for new patients during their 
clinical evaluation using the following approaches: De-
mographic characteristics are assessed through questions 
to the patient (about age, occupation and education level) 
and observation (sex). Family history of  type 2 diabetes is 
also assessed through questions to the patient. It is based 
on the occurrence of  diabetes in atleast one first degree 
relative (parent or sibling) or more than one second de-
gree relative (grand-parent or cousin). Presenting symp-
toms are assessed through questions to the patient about 
their health problem. Height is routinely measured using 
an improvised height metre inscribed onto the wall of  
the clinic’s examination room. It is measured with the pa-
tients standing up-right. Weight is routinely measured us-
ing a standard weighing scale. The weighing scale under-
goes regular ‘zero-correction’ at the start of  every clinic 
day. Blood pressure is routinely assessed using a standard 
aneroid manometer. 
Blood glucose is assessed using simple hand-held glucom-
eters of  the brand ‘Accu-Chek ®’ (AVIVA). Although the 
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meter uses capillary blood, the results provided are cor-
rected to provide plasma glucose levels as per the Inter-
national Federation of  Clinical Chemistry and Laboratory 
Medicine (IFCC) guidelines17. Blood is drawn from a fin-
ger prick using a lancing device or regular syringe needle. 
It is placed on special applicators which are placed in the 
glucometer. The glucometer then provides a reading after 
about five to ten seconds. The Oral Glucose Tolerance 
Test was performed according to standard procedures i.e. 
the patient ate 100mg of  commercial glucose, waited at 
the clinic, and thereafter had a blood glucose test after 
two hours. The type of  diagnostic blood glucose tests that 
patients underwent varied according to 1) the clinicians’ 
decisions guided by usual practice, 2) convenience to the 
patient and the patient’s willingness to return for more 
valid tests and 3) the fact that un-confirmatory tests like 
random blood sugar (RBS) could be sufficient if  the clin-
ical signs are strongly pointing to diabetes. As such, the 
diagnostic procedures did not always conform to WHO 
recommendations. 
The test used to confirm the diagnosis of  diabetes for 
most patients (93/103; 90%) was the random blood sugar 
test (Table 1). For the majority of  patients, their diagnosis 
was confirmed on the basis of  a single blood glucose test 
(83.5%) including 73.8% confirmed on the basis of  a sin-
gle random blood sugar test and 8.7% confirmed with a 
single Fasting Plasma Glucose (FPG) test. Only 1 patient 
had an Oral Glucose Tolerance test (OGTT) (Table 1). 
Only 16.5% of  patients underwent two different blood 
glucose tests (RBS and FPG). All patients who underwent 
two blood glucose tests were found to have initially tested 
negative with the RBS test, following which an FPG test 
was ordered. Among other tests conducted, about 10% 
of  patients had a chest x-ray, while about 17% had an eye 
examination done (Table 1). 
Table 1: Tests undertaken on new diabetes patients 
                                                                                                       
Characteristic No % 
Blood sugar tests conducted:     
Random Blood Sugar 93 90.3 
Fasting Plasma Glucose 26 25.2 
Urine sugar or other urine parameters 17 16.5 
Oral Glucose Tolerance Test 1 1.0 
Other tests conducted:     
Chest X-ray 10 9.7 
Full Haemogram/CBC 1 1.0 
Eye examination 17 16.5 
 
 Initial management decision referred to the initial treat-
ment strategy that the clinician prescribed on the visit at 
which a diagnosis of  diabetes was made, based on their 
assessment of  the patients’ severity of  illness.The man-
agement options included:  management as an out-pa-
tient either with lifestyle therapy only or with oral hypo-
glycaemics (classified as moderate illness at diagnosis) or 
management with insulin with or without initial admis-
sion (classified as severe illness at initial diagnosis). This 
information was abstracted from the patients’ journals. 
In the study context, management decisions for patients 
were taken by clinicians guided by the Uganda Clinical 
Guidelines14. 
Respondents who reported having any first degree rel-
ative or more than one second degree relative with dia-
betes were classified as having a family history of  type 
2 diabetes. Duration since onset of  illness was catego-
rised into less than 1 year and ≥ 1 year. Using the pa-
tients’ anthropometric data,body mass index (BMI) was 
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computed as weight (in kilograms) divided by the square 
of  height (in metres). BMI was classified using standard 
WHO cut-offs: A BMI less than 18.5 Kgm-2 was classi-
fied as underweight, that of  18.5-24.9 as normal, that of  
25-29.9 Kgm-2 was classified as overweight while a BMI 
≥ 30 Kgm-2 was classified as obese18.  Blood pressure was 
also classified using the standard World Health Organi-
sation (WHO) cut-offs19. A participant was classified as 
having high blood pressure if  his/her diastolic BP was 
≥90mmHg or their systolic BP was ≥140mmHg or if  
they were already on anti-hypertension medications at the 
time of  diabetes diagnosis. Classification of  blood glu-
cose was based on the standard cut-offs by the WHO. For 
Random Blood Sugar, a reading ≥11mmoll-1 was classi-
fied as diabetes. For Fasting Plasma Glucose, a cut off  of  
≥7mmol-1 indicated diabetes while for the Oral Glucose 
Tolerance Test (OGTT), a cut off  of  ≥ 7.8mmoll-1 was 
classified as diabetes7. 
Classification of  type 1 or type 2 diabetes is a challenge in 
this setting.  In the standard classification, type 1 diabetes 
is affirmed if  tests show absolute deficiency of  insulin 
while type-2 diabetes is considered among patients who 
have high levels of  exogenous insulin20. Because the dia-
betes clinic in our study setting has no capacity to deter-
mine insulin levels, their routine practice is to classify all 
patients aged 20 years or less as type 1 diabetes and all 
older patients as type-2 diabetes. For this study’s analysis 
however, a patient was presumed to have type 1 diabetes 
if  he/she was aged less than 40 years, and also had a low 
or normal BMI20,21. All patients older than 40 years and 
those younger than 40 but with a high BMI were pre-
sumed to have type 2 diabetes20,21. The 40 year cut-off  
was selected other than 35 or 30 years because the study 
district is a relatively low risk setting for type 2 diabetes20.
Statistical analysis
Data was entered into SPSS Version 17 statistical software. 
The statistical analysis conducted was mainly descriptive. 
Frequencies were run for key background demograph-
ic characteristics and clinical features that were assessed 
in this study – findings were presented as frequencies 
and proportions. Cross-tabulations were conducted for 
demographic characteristics associated with severity of  
illness at initial diagnosis. Statistical differences between 
the comparison and indicator categories of  the indepen-
dent variables with the dependent variable (Severity of  
illness at diagnosis) were tested using Odds Ratios and 
p-values, at a significance level of  α=0.05. Comparisons 
that yielded statistically significant outcomes at bivariate 
analysis were subjected to logistic regression to control 
for possible confounding. Key findings from the analysis 
are presented in summary tables.
Ethical considerations
This study was presented to and approved by the High-
er Degrees Research and Ethics Committee of  Makere-
re University School of  Public Health. The main ethical 
challenge encountered in implementation of  the study 
was the shortage of  diagnostic devices especially for 
blood glucose testing at the diabetes clinic. This was miti-
gated by supplying supplemental glucometers and testing 
kits to the clinic. The research team also ensured that the 
data abstraction tools did not capture the patients’ names 
as a measure for confidentiality. Other ethical challenges 
arose from the finding that some diagnostic procedures 
for type 2 diabetes used in the clinic were not in line with 
recommendations from current international guidelines 
for diagnosis of  the disease. However, these procedures 
are part of  the usual standard of  care in the study setting. 
Results
Demographic characteristics of  newly diagnosed di-
abetes patients
The mean age of  incident diabetes patients was 49 years 
(SD=14.4 years; range 5 to 86 years). The median and 
modal age was 50 years, suggesting that the age distribu-
tion of  newly diagnosed diabetes cases is normal. Based 
on the standard deviation, about two thirds of  new dia-
betes patients (68%) lie between the ages 35 to 63 years. 
About one quarter of  incident diabetes cases are below 
the age of  43 years. Other demographic characteristics 
of  newly diagnosed diabetes patients are summarized in 
Table 2. From the table, three quarters (77%) of  new-
ly diagnosed diabetes patients were below the age of  60 
years. The majority of  newly diagnosed diabetes patients 
(58/103; 56%) were aged between 40-49 years and 50-
59 years (Table 2). Two thirds of  newly diagnosed dia-
betes patients were peasants/un-skilled workers. About 
two thirds had not had formal education beyond primary 
school. A family history of  diabetes was reported in 20% 
of  newly diagnosed diabetes patients (Table 2). A slight 
majority of  newly diagnosed diabetes patients were fe-
males (52%).
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Table 2: Demographic characteristics of newly diagnosed diabetes patients 
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  Clinical characteristics of  new diabetes patients 
The most common symptom at presentation of  new dia-
betes patients was frequent passing of  urine. This symp-
tom was reported by every patient assessed during the 
study period (Table 3). Frequent urination was followed 
by frequent drinking/thirst (81/103, i.e.79% of  all new 
patients) and general body weakness (52/103, i.e.51%). 
Moderately occurring symptoms included: blurred vision 
(38%), frequent eating (33%), excessive sweating (27%), 
joint pains (22%), numbness (21%) and headache (21%) 
(Table 3).  Forty-two percent of  new diabetes patients 
reported a duration of  less than 1 year since onset of  
symptoms.  The mean time from onset of  symptoms to 
diagnosis of  diabetes was 1.4 years (median 1 year).
About one fifth of  patients (19%) were obese while slight-
ly over one quarter (26%) were overweight (Table 3).  Di-
abetes patients had a high prevalence of  overweight and 
obesity: 45.6% of  them (i.e. 47/103) were overweight or 
obese while one fifth of  the patients (20/103) were obese. 
It should be noted however that the majority (45/103 or 
43.7%) of  new diabetes patients have a normal BMI. 
Additionally, 11 patients (10.7%) were underweight. The 
mean BMI at presentation of  new diabetes patients was 
24.7 (median 24; range 13.3 – 44.6). About 48% (49/103) 
of  newly diagnosed diabetes patients had high blood 
pressure at presentation.
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Table 3: Presenting characteristics of new diabetes patients 
 
Characteristic No % 
Symptoms at presentation:   
Frequent passing of urine 103 100.0 
Frequent drinking/thirst 81 78.6 
General body weakness 52 50.5 
Blurred vision 39 37.9 
Frequent eating/desire to eat 34 33.0 
Excessive sweating 28 27.2 
Joint pains 23 22.3 
Numbness of limbs 22 21.4 
Headache 22 21.4 
Loss of body weight 13 12.6 
Dizziness 7 6.8 
Body itching 7 6.8 
Loss of appetite 6 5.8 
Gaining of body weight 6 5.8 
General body pain 5 4.9 
Abdominal pains 4 3.9 
Blindness 4 3.9 
Hypertension 3 2.9 
Frequent urination, thirst and eating 2 1.9 
Fever 2 1.9 
Chest pain 2 1.9 
Numbness/Paraesthesias 2 1.9 
Nausea 1 1.0 
Duration since onset of symptoms:   
<1 year 43 41.7 
≥1 year 60 58.3 
BMI at presentation:   
Under-weight 11 10.7 
Normal 45 43.7 
Overweight 27 26.2 
Obese 20 19.4 
BP at presentation:   
Normal 54 52.4 
Hypertensive 49 47.6 
Type of diabetes:†   
Presumed to be type 1 diabetes 14 13.6 
Presumed to be type 2 diabetes 89 86.4 
Initial management track:‡   
   Moderately ill     
Outpatient on oral hypoglycaemics 73 70.9 
Outpatient on lifestyle therapy only 1 1.0 
   Severely ill   
Outpatient on insulin 21 20.4 
Initially admitted; discharged on 
insulin 
8 7.8 
          † ‘Presumed’ to be type 1 diabetes if the patient was below 40 years of age with a normal or underweight BMI;              
         ‘Presumed’ to be type 2 diabetes for all patients above 40 years, and those below 40 years but with a high BMI.   
          This classification is considered presumptive because it was not possible to determine those who had absolute  
          insulin deficiency vs. high exogenous insulin 
         ‡Based on clinician’s assessment of severity of illness 
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Regarding type of  diabetes, 13.6% of  patients fit the clin-
ical criteria for presumptive classification as type 1 diabe-
tes while 86.4% fit the criteria for type 2 diabetes. With 
regard to the initial management, the majority of  patients 
were initially managed as out-patients on oral hypoglycae-
mic drugs (71%) while one fifth of  the patients (20.4%) 
were initiated on insulin treatment as out-patients. About 
8% of  patients were initially admitted for treatment of  
emergency complications of  diabetes. Only one patient 
(1.0%) was managed with lifestyle measures only. Of  14 
patients that fit the presumptive definition for type-1 dia-
betes used for this study (i.e. aged less than 40 years with 
a normal or low BMI), 6 patients (42.9%) were initially 
treated with oral hypoglycaemic drugs). However, 3 of  
the patients who fit the presumptive definition for type-1 
diabetes were also found to be underweight, and all three 
were initiated on insulin.
Distribution of  blood glucose measurements
The mean Random Blood Sugar level for 93 patients 
who underwent this test was 16.0 mmolL-1 (median 14.0; 
mode 24.7). However, the range was 5.4 - 37.0 mmolL-1 
implying that some patients’ random blood sugar levels 
were not in the range of  diabetes. The mean FPG level 
for 26 patients who underwent the FPG test was 14.7 
mmolL-1(median 12.7; mode 9.3; range 7.8 - 27.4) mean-
ing that all patients who underwent the FPG test turned 
out with blood glucose levels in the range of  diabetes. 
Of  the 93 diabetes patients that underwent the Random 
Blood Sugar test, 25 (26.9%) did not have blood sugar 
levels in the range of  diabetes. Only 17 of  these under-
went a follow-on FPG test to affirm their diabetes status, 
meaning that 8 patients (7.8%) were treated presumptive-
ly as having diabetes without confirmatory blood glucose 
testvalues showing their blood glucose level to be in the 
diabetes range. 
Demographic and clinical characteristics associated 
with initial management decision
Adjusting for other demographic and clinical characteris-
tics assessed in this study, the severity of  illness at presen-
tation was found to be significantly associated with two 
factors, both of  which were demographic: age and occu-
pation. Patients in the age-group 40-59 and those aged 
60 years and older were 90% and 80% less likely to be 
severely ill at initial presentation compared to those aged 
less than 40 years (OR 0.1; 95% CI 0.03-0.35 and OR 
0.2; 95% CI 0.04-0.64 respectively). Patients employed as 
skilled workers were 80% less likely to be severely ill at 
presentation compared to those whose occupation was 
peasants or unskilled workers (OR 0.2; 95% CI 0.04-0.71). 
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Discussion
This study describes the clinical characteristics of  newly 
diagnosed diabetes patients in a rural hospital in Eastern 
Uganda. The setting is a predominantly rural low income 
district. We show that three fifth of  diabetes patients are 
aged between 40 and 59 years, and two thirds are within 
the age range of  35 to 65 years. Two clinical symptoms 
are present in almost all diabetes patients: Frequent uri-
nation and frequent drinking/thirst. The mean duration 
from onset of  symptoms to diagnosis of  diabetes was 1.4 
years. The prevalence of  concurrent non-communicable 
disease related risk factors for (hypertension and over-
weight) among diabetes patients was much higher than 
that in the general population. The majority of  new pa-
tients were classified and hence treated as having ‘moder-
ate illness’ at diagnosis.
Our study shows that the majority of  new diabetes pa-
tients are aged between 40 and 59 years, with a mean age 
of  49 years. These rural patients are therefore on average 
older than those seen at Uganda’s National Referral hos-
pital, in whom the mean age was 45 years with incidence 
peaking between 40 to 49 years12. This is consistent with 
findings from a population-based survey of  the preva-
lence of  diabetes in the same setting which showed that 
diabetes increased consistently with age22. However, the 
age of  patients in our study setting contrasts substantially 
with that from higher income countries where diabetes 
incidence is estimated to peak between 60 and 70 years23. 
In our study, 75% of  new diabetes cases were found to be 
aged below 60 years. These findings imply that diabetes 
is occurring in significantly younger age groups in our 
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Table 4: Demographic and clinical characteristics associated with severity of hyperglycaemia at presentation 
 
Characteristic Moderately ill at 
presentation‡ 
Severely ill at 
presentation† 
COR p-value 95% CI AOR p-value 95% CI 
 No % No %       
Age:           
<40 8 (38.1) 13 (61.9) 1.0   1.0   
40-59 49 (84.5) 9 (15.5) 0.1 <0.001** 0.04-0.35 0.1 >0.001 0.03-0.35** 
60+ 17 (70.8) 7 (29.2) 0.3 0.031** 0.07-0.88 0.2 0.011 0.04-0.64** 
Sex:           
Male 37 (75.5) 12 (24.5) 1.0   1.0   
Female 37 (68.5) 17 (31.5) 1.4 0.432 0.60-3.36 1.4 0.566 0.47-4.04 
Occupation:           
Unskilled 45 (65.2) 24 (34.8) 1.0   1.0   
Skilled 29 (85.3) 5 (14.7) 0.1 0.033** 0.11-0.94 0.2 0.016 0.04-0.71** 
Education level:           
Primary and below 51 (75.0) 17 (25.0) 1.0   1.0   
Post primary 23 (65.7) 12 (34.3) 1.6 0.321 0.64-3.80 2.0 0.232 0.63-6.62 
Duration since onset:           
<1 year 27 62.8 16 37.2 1.0   1.0   
≥1 year 47 78.3 13 21.7 0.5 0.087* 0.20-1.17 0.5 0.170 0.18-1.35 
BMI:           
Normal 39 69.6 17 30.4 1.0   1.0   
Overweight/obese 35 74.5 12 25.5 1.2 0.588 0.33-1.88 1.1 0.906 0.37-3.05 
BP:           
Normal 38 70.4 16 29.6 1.0   1.0   
Hypertensive 36 73.5 13 26.5 0.9 0.727 0.36-2.03 1.4 0.505 0.49-4.23 
             † Initially treated with hypoglycaemic drugs or lifestyle measures 
             ‡ Initially treated with insulin or admission 
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study setting, compared to higher income countries. The 
World Health Organisation estimates that about 30% of  
NCD related deaths in LMICs occur in people aged less 
than 60 years, compared to 13% in the HICs24. This find-
ing highlights the urgency to put in place measures for 
prevention and early detection of  diabetes in rural low 
income settings. 
Frequent urination and frequent thirst were found in al-
most all new diabetes patients. These symptoms are as-
sociated with substantially developed disease and they 
imply that by the time patients present with diabetes in 
the context where this study was conducted, their disease 
has progressed substantially. This is consistent with stud-
ies that show late presentation of  diabetes in low income 
countries11. Nambuya and Otim also found substantial 
prevalence of  classical symptoms and complications 
among newly diagnosed diabetes patients at Uganda’s 
National Referral Hospital12. Late presentation in this set-
ting is probably attributed to low patient awareness about 
diabetes and low clinical suspicion of  diabetes by health 
workers. Recognition of  diabetes is in many low income 
countries dependent on the presence of  overt symptoms 
as current primary care services do not include diabetes 
screening for high risk individuals11. Since most patients 
first go to primary care facilities before going to hospitals, 
it is critical that lower level facilities are equipped with 
trained personnel and appropriate equipment to identify 
high risk persons for diabetes. 
Even when symptoms have appeared, our study findings 
show that patients take an average of  one-and-a-half  
years to get a diabetes diagnosis. This finding points to a 
health system setting (including first level health workers, 
diagnostic algorithms, and service delivery packages) that 
does not have sufficient capacity to detect early symptom-
atic cases. Patients therefore have to go through a long 
tortuous path before a definitive diagnosis of  diabetes is 
made. Primary health care systems in this setting have for 
long been designed to address infectious diseases25, and 
would need significant re-tuning for chronic care26,27. 
There is a call for simplification of  diagnostic tools for 
diabetes28,29. Lyon and colleagues have argued that in re-
source limited settings where point-of-care diagnostics 
are lacking, symptom-based tools may be the best hope 
for early identification of  disease30. Since all diabetes suf-
ferers in our study were found to have frequent passing of  
urine or frequent drinking/thirst, these symptoms can be 
useful pre-screening filters for possible early suspicion of  
undiagnosed diabetes cases at the lowest level of  health 
facilities so that early referral for further investigations is 
prompted. Out-patients aged 35 to 65 years seeking care 
in first level health facilities could be passively asked about 
presence of  these symptoms, their presence indicating a 
high likelihood of  diabetes. Combinations of  other signs 
and symptoms that were found to be common in diabetes 
patients (overweight or obesity, hypertension and body 
weakness) can also enhance the predictive value of  these 
assessments. 
This study found a high prevalence of  concurrent car-
diovascular risk factors among newly diagnosed diabetes 
patients. The prevalence of  obesity was five times high-
er than its prevalence in the general population of  Ig-
anga district in a recent study in the same population31. 
Nambuya and Otim also found similar levels of  obesity 
among new diabetes patients seen at the National Refer-
ral Hospital in Uganda12. The prevalence of  both over-
weight and obesity in our study participants was 2.5 times 
higher than that found among people aged 35-60 years in 
a recent national level survey31. Likewise, the prevalence 
of  hypertension in our study was twice that found among 
people aged 35-60 years in Iganga District31,32 and at the 
national level10. Hypertension has been determined to be 
the most frequent concurrent cardiovascular risk factor 
among diabetes patients in Africa, ranging from 44-65% 
prevalence in different studies8. In addition to the need to 
control blood glucose therefore, diabetes patients in this 
setting require multiple treatments and lifestyle education 
to address other risk factors like obesity and hyperten-
sion.
The majority of  new diabetes patients were classified as 
having moderate illness at diagnosis, and were therefore 
managed with oral hypoglycaemic drugs. This finding is 
in contrast to studies that show that most people with 
type 2 diabetes present when the disease is severe5,11. 
However, the predominance of  oral hypoglycaemic drugs 
as the initial treatment, even among patients who suit the 
clinical picture of  type 1 diabetes, are associated with in-
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ability to assess insulin levels at diagnosis, difficulties in 
ensuring access to insulin, low levels of  patient autonomy 
in self-management, challenges in management of  the 
insulin cold chain, as well as inadequacies in the intense 
follow-up required for patients on insulin in this setting, 
which drive clinicians to initiate less patients on insulin 
than required.
The finding that one quarter of  patients’ random blood 
sugar levels were below the diabetes range strengthens 
the case for the ineffectiveness of  random blood sugar as 
a screening test for diabetes. Current global guidelines for 
diabetes management discourage the use of  RBS as a di-
agnostic test6,7, yet it is the most widely used test in Ugan-
da. The finding that all patients tested with the FPG test 
returned positive results for diabetes may imply that FPG 
has a high diagnostic value for diabetes in this setting if  
combined with presence of  symptoms. It is consistent 
with studies that have shown that both FPG and HbA1C 
have a relatively high accuracy at current cut-offs33.
The main limitations of  this study arose from the study 
context. In this rural low resource setting, the only di-
abetes clinic in the districts relies majorly on random 
blood glucose for confirmation of  diabetes. However, 
combination of  the RBS with clinical signs, and the late 
presentation of  patients in settings such as these3,11 in-
creases the predictive value of  the RBS test. In the study 
setting, blood glucose tests are conducted using point-
of-care rapid test kits, which might affect accuracy of  the 
results. However, there is evidence that modern point-of-
care tests have sufficiently high levels of  accuracy34,35. The 
existence of  patients treated without evidence of  a high 
blood sugar also raises concerns, but affirms the need for 
capacity building in diabetes care. The absence of  tests 
to assess insulin levels or autoimmune reactions meant 
that it was not possible to have accurate classification of  
type 1 and type 2 diabetes. This was partly mitigated by 
using practical clinical criteria for classification, whose 
limitation is acknowledged. The rate of  patient flow af-
fected the sample size, limiting the study utility to main-
ly descriptive purposes. The setting of  the study being a 
hospital meant that the findings are mainly generalizable 
to hospital settings. However, this being the only diabetes 
clinic in the district meant that patients were drawn from 
the entire district.
In conclusion, new diabetes patients in this predominant-
ly rural subsistence-based setting are on average substan-
tially younger than those in higher income countries. The 
majority of  patients present with classical symptoms of  
diabetes, showing that the disease is fairly advanced at di-
agnosis. The patterns of  resort and the system failures 
that these patients experience before diagnosis should be 
investigated. There is a need for increased skills-building 
for first line health workers in rural hospitals to increase 
their acumen in clinical suspicion of  diabetes, and a need 
for enhanced clinical algorithms to support risk assess-
ment and early diagnosis of  diabetes. Because two clini-
cal symptoms are present in almost all diabetes patients 
(frequent urination and frequent drinking/thirst), and 
because most new patients are aged between 40-59, all 
adults within this age-group presenting to the out-patient 
department should be asked whether they have these 
symptoms, and investigated with a presumptive blood 
glucose measurement if  they report to have them. All 
diabetes patients in this setting need to be assessed and 
appropriately managed for hypertension and obesity. 
Key messages
• In this rural low income setting in Eastern Uganda, two-
thirds of  new diabetes patients are aged between 35 to 65 
years. This age-group should be the target of  efforts at 
early detection, more especially those aged 40-59, where 
three fifths of  new patients lie.
• Because two clinical symptoms are present in almost all 
diabetes patients (frequent urination and frequent drink-
ing/thirst), all clients aged 40-59 presenting to the out-
patient departments should be asked whether they have 
these symptoms.
• 50% of  newly diagnosed diabetes patients had car-
dio-vascular or metabolic co-morbidities. All diabetes 
patients should be assessed for overweight and hyperten-
sion, which should also be prioritised in their treatment 
plan.
• Though widely used as a diagnostic tool in this setting, 
random blood sugar is not effective as it would misclassi-
fy about one quarter of  patients as having a normal blood 
glucose.
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